Vaccine Watch: Pfizer, Moderna move closer to authorization

ABC’s Bob Woodruff discusses Pfizer's and Moderna’s advances toward the Food and Drug Administration's approval of a COVID-19 vaccine. Both companies say their candidates are up to 95% effective.